Strickland SP. Politics, Science, and Dread Disease. Cambridge, MA: Harvard University Press; 1972.
Dublin LI. Health Progress, 1936 to 1945. New York, NY: Metropolitan Life Insurance Co. N.D.
Fox DM. Power and Illness: The Failure and Future of American Health Policy. Berkeley, CA: University of California Press; 1993.
Etheridge EW. Sentinel for Health: A History of the Centers for Disease Control. Berkeley, CA: University of California Press; 1992.
Mountin JW. Changing concepts of basic local public health services. In: Selected Papers of Joseph W. Mountin, M.D. Joseph W. Mountin Memorial Committee; 1956.
Dawber TR. The Framingham Study: The Epidemiology of Atherosclerotic Disease. Cambridge, MA: Harvard University Press; 1980.
Oppenheimer GM. Becoming the Framingham Study 1947–1950. Am J Public Health. 2005;95:602–10.
Marks HM. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900–1990. Cambridge: Cambridge University Press; 1997.
Keys A. Nutrition in relation to the etiology and the course of degenerative diseases. J Am Diet Assoc. 1948;24:281–5.
Katz LN, Stamler J, Pick R. Nutrition and Atherosclerosis. Philadelphia, PA: Lea & Febiger; 1958.
Aronowitz RA. The social construction of coronary heart disease risk factors. In: Aronowitz RA, editor. Making Sense of Illness: Science, Society and Disease. New York, NY: Cambridge University Press; 1998. p.111–44.
White PD. Heart Disease. 3rd edition. New York, NY: The Macmillan Co; 1944.
Moriyama IM, Woolsey TD, Stamler J. Observations on possible factors responsible for the sex and race trends in cardiovascular-renal mortality in the United States. J Chronic Dis. 1958;7:401–12.
National Heart Institute. Circular number 7. October 1951. Cited in Katz LN, Stamler J. Experimental Atherosclerosis. Springfeld, IL: Charles C. Thomas; 1953.
Meadors G. Minutes. In: Records of the National Institutes of Health, National Advisory Heart Council, Box 21, National Archives, College Park, Md. June 7, 1948.
Clausen JA. Research on the American soldier as a career contingency. Soc Psychol Q. 1984;47:207–13.
Moore F. Correspondence to Van Slyke CJ. August 26, 1949. In: Papers of the National Heart, Lung, and Blood Institute, Framingham Heart Disease Epidemiology Study (General) Folder.
Meadors G. Correspondence to Boone B, July 19, 1947. In: Papers of the National Heart, Lung, and Blood Institute, Epidemiology Correspondence Folder.
Dawber TR, Moore FE, Mann GV. Coronary heart disease in the Framingham Study. Am J Public Health. 1957;47:4–24.
Doyle JT, Dawber TR, Kannel WB, Heslin AS, Kahn H. Cigarette smoking and coronary heart disease: combined experience of the Framingham and Albany studies. N Engl J Med. 1962;266:796–801.
Cornfeld J. Joint dependence of risk of coronary heart disease in serum cholesterol and systolic blood pressure: a discriminant function analysis. Fed Proc. 1962;21:58–61.
Rothstein W. Public Health and the Risk Factor: A History of an Uneven Medical Revolution. Rochester, NY: University of Rochester Press; 2003.
Aronowitz R. The social construction of coronary heart disease risk factors. In: Aronowitz R. Making Sense of Illness: Science, Society and Disease. New York, NY: Cambridge University Press; 1998. p.111–44.
Dawber TR, Kannel WB. Application of epidemiology of coronary heart disease to medical practice. Modern Medicine. 1962;30:85–101.
Max H, DeMets DL, Ware JH. Early Methodological Developments for Clinical Trials at the National Heart, Lung and Blood Institute. Stat Med. 1990;9:881–92.
Turpeinen O, Miettinen M, Karvonen MJ, Roine P, Pekkarinen M, Lehtosuo EJ, Alivirta P. Dietary prevention of coronary heart disease: long-term experiment. I. Observations on male subjects. Am J Clin Nutr. 1968;21:255–76.
Dayton S, Pearce ML, Hashimoto S, Fakler LJ, Hiscock E, Dixon WJ. A controlled clinical trial of a diet high in unsaturated fat. N Engl J Med. 1962;266:1017–23.
National Diet-Study Recruitment Group. The National Diet-Heart Study final report. Circulation. 1968;37:S119–24.
National Heart Institute. Diet-Heart Review Panel. Mass Field Trials of the Diet Heart Question. New York, NY: American Heart Association; 1969.
National Heart Institute. Diet-Heart Review Panel, National Heart and Lung Institute Task Force. Arteriosclerosis, A Report by the National Heart and Lung Institute Task Force on Arteriosclerosis. Washington, DC: U.S. Printing Office; 1971.
Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. JAMA. 1975;231:360–81.
National Advisory Health Council. Transcripts of Proceedings, 62. 1975.
Freis E.D. Reminiscences of the Veterans Administration trial of the treatment of hypertension. Hypertension. 1990;16:472–5.
World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-year results. Lancet. 1986;1(8486):869–72.
Hjermann I, Holme I, Leren P. Oslo Study Diet and AntiSmoking Trial. Results after 102 months. Am J Med. 1986;80:7–11.
Cooper T. Arteriosclerosis: policy, polity, and parity. Circulation. 1972;45:433–40.
Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA. 1982;248:1465–77.
Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in “mild” hypertension. Results of the Hypertension Detection and Follow-up Program. N Engl J Med. 1982;307:976–80.
Lipid Research Clinics. The Lipid Research Clinics Coronary Primary Prevention Trial results 1. Reduction in incidence of coronary heart disease. JAMA. 1984;251:351–64.
The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habits, relative weight and ECG abnormalities to the incidence of major coronary events: final report of the Pooling Project. J Chronic Dis. 1978;31:201–306.
Farquhar JW, Maccoby N, Wood PD, et al. (1977). Community education for cardiovascular health. Lancet, 1977;1:1192–5.
Keys A, et al. Coronary heart disease in seven countries. Circulation. 1970; 41:S1–211.
Blackburn H. Research and demonstrations projects in community cardiovascular disease prevention. J Public Health Policy. 1983;4:398–421.
Report of the Makarska Conference on Mass Field Trials for the Prevention of Coronary Heart Disease. International Society of Cardiology. Makarska, Yugoslavia. CVD History Archive: School of Public Health, Univ. of Minnesota; 1968. Available from URL:http://www.epi.umn.edu/cvdepi/ photo_doc.asp?id=981 (Accessed 22 December, 2011).
Puska P, et al. The North Karelia project. 20-year results and experiences. Helsinki: National Public Health Institute; 1995.
Mass Field Trials on the Prevention of Coronary Heart Disease: Perspectives and Tasks. Report of an International Working Meeting Makarska, Yugoslavia, 19–24 September, 1968. Available from URL: http://www.epi.umn.edu/cvdepi/ pdfs/Makarska%20doc.pdf (Accessed 22 December, 2011).
Farquhar JW, Fortmann SP, Maccoby N, Haskell WL, Williams PT, Flora, JA, et al. The Stanford Five-City Project: Design and methods. Am J Epidemiol. 1985;122:323–34.
Jacobs DR Jr, Luepker RV, Mittelmark MB, Folsom AR, Pirie PL, Mascili SR, et al. Communitywide prevention strategies: Evaluation design of the Minnesota Heart Health Program. J Chronic Dis. 1986;39:775–88.
Carleton RA, Lasater TM, Assaf A, Lefebvre RC, McKinlay SM. The Pawtucket Heart Health Program: an experiment in population-based disease prevention. R I Med J. 1987;70:533–8.
Murray DM. Design and analysis of community trials: Lessons from the Minnesota Heart Health Program. Am J Epidemiol. 1995;142:569–75.
Blackburn H. Community programmes in coronary heart disease prevention and health promotion: Changing community behavior. In: Coronary Heart Disease Epidemiology. Marmot M, Elliott P, editors. New York, NY: Oxford University Press; 1992.
Winkleby MA, Feldman HA, Murray DM. Joint analysis of three U.S. community intervention trials for reduction of cardiovascular disease risk. J Clin Epidemiol. 1997;50:6545–658.
Kannisto V. Kuolemansyyt väestöllisinä tekijöinä Suomessa. [Finnish]: Causes of death as demographic factors in Finland. Helsinki: Kansantaloudellinen yhdistys; 1947.
Keys A. The cholesterol problem. Voeding. 1952;13:539–55.
Keys A, Karvonen MJ, Fidanza F. Serum-cholesterol studies in Finland. Lancet. 1958;2:175–8.
Roine P., Pekkarinen M., Karvonen M.J., Kihlberg J. (1958). Diet and cardiovascular disease in Finland. Lancet. 1958;2;173–5.
Editorial. Shot-gun prevention? Int J Epidemiol. 1973;2:219–20.
Puska P, Tuomilehto, Nissinen A, Vartiainen E. The North Karelia Project 20 year results and experiences. Helsinki: National Public Health Institute; 1995.
Puska P, Vartiainen E, Laatikainen T, Jousilahti P, Paavola M, editors. The North Karelia Project: From North Karelia to National Action. Helsinki: The National Institute for Health and Welfare (THL); 2009.
Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Männistö S, Sundvall J, et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol. 2010;39:504–18.
Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005;162:764–73.
Puska P, Nissinen A, Tuomilehto J, Salonen JT, Koskela K, McAlister A, et al. The community-based strategy to prevent coronary heart diseases: conclusions from the ten years of the North Karelia Project. Ann Rev Public Health. 1985;6:47–193.
Puska P, Ståhl T. Health in All Policies–The Finnish Initiative: background, principles, and current issues. Ann Rev Public Health. 2010;31:27.1–27.14.
Community Intervention Trial for Smoking Cessation (COMMIT): I. cohort results from a four-year community intervention. Am J Public Health. 1995;85:183–92.
Luepker RV. Community trials. Preventive Med. 1994;23:602–5.
Luepker RV, Murray DM, Jacobs DR, Mittlemark MB, Bracht N, Carlaw R, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health. 1994;94:1383–93.
Susser M. The tribulations of trials-interventions in communities. (Editorial) Am J Public Health, 1995;85:156–8.